Markets

Psyence Biomedical Completes Its Additional Investment In PsyLabs Of $2,599,896

Oct 21, 2026 · 07:06 AM ET· updated 2h ago

Psyence Biomedical Ltd. (NASDAQ:PBM) ("Psyence BioMed" or the "Company") today announced that both milestones attached to its backstop subscription commitment in Psyence Labs Ltd. ("PsyLabs")

Why It Matters

Psyence Biomedical put about 2.6 million dollars into its partner company PsyLabs. When a company invests more money into a business, it shows they believe in it and want to help it grow.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

PBM4.25

+0.13 (+3.16%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.